Inclusion criteria |
Diagnosis of primary Sjögren syndrome based on the American-European Consensus criteria [13] |
|
Erythrocyte sedimentation rate of greater than 25 mm/hour and hypergammaglobulinemia (>1,500 mg/dL) |
|
Presence of anti-SSA and/or SSB antibodies and/or rheumatoid factor |
|
Requirement of artificial teardrops due to symptomatic sicca syndrome |
|
Inadequate response or intolerance of prior treatment with hydroxychloroquine and/or azathioprine |
|
Adequate contraception for females of childbearing potential |
|
|
Exclusion criteria |
Age below 18 or above 75 years |
|
Secondary Sjögren syndrome |
|
History of cancer, severe infections, or other uncontrolled diseases |
|
Treatment with concomitant disease-modifying antirheumatic drugs within the last 8 weeks before baseline evaluation |
|
Prednisolone dose of greater than 5 mg/day or changes of prednisolone dose within the last 4 weeks before baseline |
|
Use of secretagogues (for example, pilocarpine and civemeline) or medications that potentially diminish exocrine gland function (for example, tricyclic antidepressants and anticholinergic drugs) |
|
Pregnant or lactating women |